Mumbai-based IT services and solutions provider Hexaware Technologies is working with Artificial Intelligence (AI) security service provider Abluva to provide secure AI solutions for the life sciences sector. The partnership aims to tackle the security challenges posed by autonomous AI systems essential for biological discovery, clinical trials, patient data management, and industry commercial operations.
This collaboration aims to help AI systems operate within a secure, compliant, and auditable framework. The need for robust security is growing as life science organizations embrace AI to streamline research, enhance patient outcomes and increase efficiency. Autonomous AI agents that can independently perform tasks such as data analysis and decision-making can introduce risk if not properly managed. The partnership seeks to address these risks while ensuring that companies can fully utilize the possibilities of AI.
Abluva’s solutions provide real-time monitoring and ensure that AI agents follow pre-defined roles and objectives to prevent fraud. This includes data masking and advanced visibility tools to protect sensitive information throughout the AI lifecycle, from development and training to deployment and continuous use. The standout feature is the system’s “self-healing” feature, automatically detecting and correcting irregular or potentially harmful AI behavior in real time, minimizing the risk of errors and violations. This is especially important in life sciences where data sensitivity and compliance for regulations such as the US HIPAA and the European Union’s GDPR are essential.
The partnership also ensures that AI systems are consistent with internal governance policies and provide transparency and accountability. This is important in clinical and research settings where AI processes large numbers of confidential patients and test data. Built-in governance and audit mechanisms help organizations avoid regulatory penalties while building trust in AI-driven processes.
“Working with Abluva, we can provide safe and advanced AI solutions to leading pharmaceutical companies and contract research institutes,” said Raj Gondhali, Vice President and Head of Clinical Solutions at Hexaware.
“Together we can provide solutions that address the unique challenges of autonomous AI in this area, allowing organizations to confidently scale their AI initiatives,” said Raj Darji, CEO of Abluva.
Amit Gautam, Chief Technology Officer of Abluva, highlighted the technical strength of the partnership. “Our secure intelligence spray provides sophisticated real-time governance for AI systems,” he said. “By partnering with Hexaware, we can bring this technology to a larger audience and address the critical need for secure AI in complex life sciences environments where data integrity and compliance are paramount.”
